Hookmeistr , if we have a limitation in age like 65 , it will mean that leronlimab will have an approval or EUA for this age , and another trial will need to be done for over 65..
What happened in USA in our CD12 , is not that common , and adjustments should be done before information was first printed .
So personally for CYDY I believe that it is good they didn't spit this 2 studies , critical and severe to 4 studies , also above and below 65 years of age ..
GLTU.
And only IMO.
Market Data 
Markets 
AI
